Axial Therapeutics CEO A. Stewart Campbell to Present at Microbiome Connect: USA 2022
01 nov. 2022 08h00 HE
|
Axial Therapeutics
WOBURN, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
CentralReach Announces Honorees for First-Ever Autism and IDD Care Awards
28 oct. 2022 11h33 HE
|
CentralReach
Fort Lauderdale, FL, Oct. 28, 2022 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD Care software, announced the winners of the company’s first-ever Autism and IDD Care...
Book Featuring Autistic Superhero Released
19 oct. 2022 12h01 HE
|
T. Alan Horne, author
SALT LAKE CITY, Oct. 19, 2022 (GLOBE NEWSWIRE) -- A new young adult novel featuring a neurodiverse superhero was released today—Advent 9, by author T. Alan Horne. Horne, who like his protagonist...
Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders
13 oct. 2022 08h00 HE
|
Sema4
Research from 19,000 patients with Autism Spectrum Disorders found approximately 90% had prior negative tests, likely contributing to a longer time to diagnosis Data will be presented at the Child...
Axial Therapeutics Expands Clinical Development Capabilities with Key Appointments
11 oct. 2022 08h00 HE
|
Axial Therapeutics
- Clinical development operations focused on ongoing Phase 2b clinical trial of AB-2004 in autism; data anticipated in 2023 - - Team also supporting additional microbiome-based small molecule...
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders
07 oct. 2022 09h20 HE
|
The Greater Cannabis Company, Inc.
BALTIMORE, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid...
Axial Therapeutics to Present at BioJapan Conference
06 oct. 2022 08h00 HE
|
Axial Therapeutics
WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
Little Leaves Behavioral Services Opens New Location in Lutherville, Maryland
29 sept. 2022 08h51 HE
|
Little Leaves
LUTHERVILLE, Md., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services for preschool-aged children on the autism...
New Scholarly Book Examines Autism Inclusion for Educators, Leaders, Individuals and Families
27 sept. 2022 07h00 HE
|
Jess Block Nerren, Ed.D.
RIVERSIDE, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- A new book, Rethinking Perception and Centering the Voices of Unique Individuals: Reframing Autism Inclusion in Praxis released Sept. 26, 2022,...
Sun West Mortgage Company Attends in Support of TACA’s 16th Annual Ante Up for Autism Fundraiser
22 sept. 2022 17h19 HE
|
Sun West Mortgage Company Inc.
LOS ANGELES, Sept. 22, 2022 (GLOBE NEWSWIRE) -- On Saturday, Sept. 24, from 5:30 p.m. until midnight The Autism Community in Action (TACA) will be hosting its 16th Annual Ante Up Autism Fundraising...